Skip to content
lifestyle.timesla.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vect-Horus
Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases
June 30, 2026
Vect-Horus appoints Claudia Fromond as new Director of R&D
March 10, 2026
Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals
February 10, 2026